CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 92 filers reported holding CUE BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is 4.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $70,000 | -59.1% | 14,281 | -5.6% | 0.03% | -52.3% |
| Q4 2021 | $171,000 | -25.0% | 15,125 | -3.3% | 0.06% | -35.0% |
| Q3 2021 | $228,000 | +18.8% | 15,636 | -4.9% | 0.10% | +26.6% |
| Q2 2021 | $192,000 | -28.6% | 16,448 | -25.4% | 0.08% | -30.7% |
| Q1 2021 | $269,000 | -0.7% | 22,053 | +1.8% | 0.11% | +1.8% |
| Q4 2020 | $271,000 | +48.9% | 21,660 | +79.6% | 0.11% | +17.9% |
| Q3 2020 | $182,000 | -45.8% | 12,061 | -12.1% | 0.10% | -40.3% |
| Q2 2020 | $336,000 | – | 13,718 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,545,573 | $3,447,000 | 1.85% |
| P.A.W. CAPITAL CORP | 200,000 | $446,000 | 0.67% |
| SANDERS MORRIS HARRIS LLC | 848,048 | $2,020,000 | 0.50% |
| Monaco Asset Management SAM | 458,851 | $1,023,000 | 0.39% |
| Bleichroeder LP | 555,000 | $1,238,000 | 0.26% |
| APOGEM CAPITAL LLC | 110,614 | $247,000 | 0.25% |
| Slate Path Capital LP | 1,483,619 | $3,308,000 | 0.22% |
| Voss Capital, LLC | 200,000 | $446,000 | 0.13% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $1,067,000 | 0.11% |
| CARLSON CAPITAL L P | 535,000 | $1,193,000 | 0.09% |